TRUSTED NEWS LEADER FOR COTTONWOOD, CAMP VERDE & THE VERDE VALLEY
Mon, Oct. 18

Column: Is the magic-COVID pill really worth $1.2 billion?

This undated image provided by Merck & Co. shows their new antiviral medication. The drug maker has said its experimental pill for people sick with COVID-19 reduced hospitalizations and deaths. The U.S. government signed a $1.2 billion deal to acquire 1.7 million courses of the drug. (Merck & Co. via AP)

This undated image provided by Merck & Co. shows their new antiviral medication. The drug maker has said its experimental pill for people sick with COVID-19 reduced hospitalizations and deaths. The U.S. government signed a $1.2 billion deal to acquire 1.7 million courses of the drug. (Merck & Co. via AP)

To view this content you must be logged in as a subscriber.
Already have a digital account? Log in here
4 WEEKS
$3

UNLIMITED

DIGITAL ACCESS

4 WEEKS

1 YEAR
$39

UNLIMITED

DIGITAL ACCESS

FOR 12 MONTHS

DAY PASS
$0.99

UNLIMITED

DIGITAL ACCESS

FOR 24 HOURS

Plans include full website access, e-Edition and exclusive online extras.
Print and Digital combo plans also available.
ALREADY A PRINT SUBSCRIBER?
Verde News subscribe logo
Donate Report a Typo Contact
Most Read
Event Calendar
Event Calendar link
Submit Event